Plasma protein binding of all
three radioligands was measured in duplicate in baseline conditions.
NHP blood plasma (500 μL) and a PBS solution (pH 7.4, KCl 0.2
mg, KH
2PO
4 0.2 mg, Na
2HPO
4 1.42 mg, NaCl 8 mg in 1 mL) were mixed with the respective radioligand
(50 μL, approx. 20 MBq in PBS). The plasma mixture was incubated
for 10 min at room temperature and a small portion (20 μL) from
each incubation mixture was measured in a well counter. A portion
(200 μL) from all individual incubation mixtures was pipetted
out into ultrafiltration tubes (Millipore
Centrifree YM-30) and centrifuged
at 3000 rpm for 15 min. Samples (20 μL) from each filtrate were
counted in a well counter. The following formula was used to calculate
the protein-bound fraction. where
Cpla (total) is the radioactivity concentration
of the incubation mixture in
plasma,
CPBS (total) is the radioactivity
concentration of the incubation mixture in PBS, and
Cpla (filtrate) and
Cpla (filtrate) are the radioactivity concentrations from filtrate samples.
Nag S., Jahan M., Tóth M., Nakao R., Varrone A, & Halldin C. (2021). PET Imaging of VMAT2 with the Novel Radioligand [18F]FE-DTBZ-d4 in Nonhuman Primates: Comparison with [11C]DTBZ and [18F]FE-DTBZ. ACS Chemical Neuroscience, 12(24), 4580-4586.